Huadong Medicine Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Liang Lv
Chief executive officer
CN¥2.4m
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 15.1yrs |
| CEO ownership | n/a |
| Management average tenure | no data |
| Board average tenure | 2.9yrs |
Recent management updates
Recent updates
Huadong Medicine Co., Ltd's (SZSE:000963) Intrinsic Value Is Potentially 77% Above Its Share Price
Apr 02
Take Care Before Diving Into The Deep End On Huadong Medicine Co., Ltd (SZSE:000963)
Feb 28Be Wary Of Huadong Medicine (SZSE:000963) And Its Returns On Capital
Feb 12An Intrinsic Calculation For Huadong Medicine Co., Ltd (SZSE:000963) Suggests It's 49% Undervalued
Dec 16We Think Huadong Medicine (SZSE:000963) Can Stay On Top Of Its Debt
Nov 29Investors Aren't Buying Huadong Medicine Co., Ltd's (SZSE:000963) Earnings
Nov 13There Are Reasons To Feel Uneasy About Huadong Medicine's (SZSE:000963) Returns On Capital
Sep 23Earnings Working Against Huadong Medicine Co., Ltd's (SZSE:000963) Share Price
Aug 05Huadong Medicine (SZSE:000963) Seems To Use Debt Rather Sparingly
Jun 28There Are Reasons To Feel Uneasy About Huadong Medicine's (SZSE:000963) Returns On Capital
Jun 10CEO
Liang Lv (50 yo)
Mr. Liang Lv has been Chairman of the Board at Huadong Medicine Co., Ltd since June 06, 2019 and serves as its General Manager. He served as Deputy General Manager of Huadong Medicine Co., Ltd since April...
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & GM | 15.1yrs | CN¥2.40m | no data | |
| Chairman of Supervisory Committee | 27.3yrs | no data | no data | |
| Independent Director | 2yrs | CN¥100.00k | no data | |
| Non-Independent Director | 8.4yrs | CN¥30.00k | no data | |
| Non-Independent Director | 5.9yrs | CN¥650.00k | no data | |
| Employee Supervisor | 5.9yrs | no data | no data | |
| Non-Independent Director | 2.9yrs | CN¥30.00k | no data | |
| Non-Independent Director | 2.9yrs | CN¥30.00k | no data | |
| Independent Director | 2.9yrs | CN¥100.00k | no data | |
| Independent Director | 2.9yrs | CN¥100.00k | no data | |
| Non-Employee Supervisor | 2.9yrs | no data | no data | |
| Director | 1.8yrs | CN¥30.00k | no data |
Experienced Board: 000963's board of directors are not considered experienced ( 2.9 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/24 19:19 |
| End of Day Share Price | 2025/05/23 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Huadong Medicine Co., Ltd is covered by 36 analysts. 12 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Changming He | BOCI Research Ltd. |
| Ethan Cui | BofA Global Research |
| Shuchang Liu | Changjiang Securities Co. LTD. |